Stifel Financial Corp boosted its position in The Cooper Companies, Inc. (NASDAQ:COO – Free Report) by 1.2% in the 3rd quarter, according to its most recent filing with the SEC. The fund owned 231,806 shares of the medical device company’s stock after purchasing an additional 2,670 shares during the period. Stifel Financial Corp owned about 0.12% of Cooper Companies worth $25,578,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors have also bought and sold shares of the company. Polar Asset Management Partners Inc. acquired a new position in Cooper Companies in the 3rd quarter valued at $1,468,000. Motley Fool Asset Management LLC lifted its holdings in shares of Cooper Companies by 1.7% during the third quarter. Motley Fool Asset Management LLC now owns 70,425 shares of the medical device company’s stock worth $7,631,000 after buying an additional 1,151 shares in the last quarter. Ingalls & Snyder LLC bought a new stake in shares of Cooper Companies in the third quarter valued at about $215,000. Investment Management Corp of Ontario grew its stake in shares of Cooper Companies by 52.9% in the third quarter. Investment Management Corp of Ontario now owns 6,644 shares of the medical device company’s stock valued at $733,000 after acquiring an additional 2,300 shares in the last quarter. Finally, HighTower Advisors LLC increased its position in Cooper Companies by 11.7% during the third quarter. HighTower Advisors LLC now owns 20,506 shares of the medical device company’s stock worth $2,261,000 after acquiring an additional 2,155 shares during the period. Institutional investors own 24.39% of the company’s stock.
Insider Buying and Selling at Cooper Companies
In other Cooper Companies news, CAO Agostino Ricupati sold 1,601 shares of the company’s stock in a transaction dated Tuesday, September 10th. The stock was sold at an average price of $108.03, for a total value of $172,956.03. Following the sale, the chief accounting officer now owns 4,818 shares in the company, valued at approximately $520,488.54. The trade was a 24.94 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Albert G. White III sold 114,992 shares of the firm’s stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total value of $12,710,065.76. Following the transaction, the chief executive officer now owns 165,273 shares of the company’s stock, valued at $18,267,624.69. This trade represents a 41.03 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Corporate insiders own 2.00% of the company’s stock.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on COO
Cooper Companies Trading Down 4.4 %
NASDAQ COO opened at $98.70 on Monday. The Cooper Companies, Inc. has a twelve month low of $82.69 and a twelve month high of $112.38. The business’s fifty day moving average is $104.49 and its 200 day moving average is $98.81. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33. The company has a market cap of $19.66 billion, a price-to-earnings ratio of 50.62, a price-to-earnings-growth ratio of 2.28 and a beta of 0.97.
Cooper Companies (NASDAQ:COO – Get Free Report) last announced its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The business’s revenue for the quarter was up 9.8% on a year-over-year basis. During the same period last year, the firm posted $0.87 earnings per share. As a group, sell-side analysts expect that The Cooper Companies, Inc. will post 4.03 EPS for the current fiscal year.
Cooper Companies Company Profile
The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.
Featured Articles
- Five stocks we like better than Cooper Companies
- 3 Monster Growth Stocks to Buy Now
- Guidewire Software Provides Long-Awaited Buying Opportunity
- CD Calculator: Certificate of Deposit Calculator
- What’s Behind These 3 Recent Analyst Stock Upgrades?
- What is the Hang Seng index?
- Fast-Growing Companies That Are Still Undervalued
Want to see what other hedge funds are holding COO? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Cooper Companies, Inc. (NASDAQ:COO – Free Report).
Receive News & Ratings for Cooper Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies and related companies with MarketBeat.com's FREE daily email newsletter.